Načítá se...
HGF-independent Potentiation of EGFR Action by c-Met
The c-Met receptor is a potential therapeutic target for non-small cell lung cancer (NSCLC). Signaling interactions between c-Met and the mutant Epidermal Growth Factor Receptor (EGFR) have been studied extensively, but signaling intermediates and biological consequences of lateral signaling to c-Me...
Uloženo v:
Hlavní autoři: | , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126872/ https://ncbi.nlm.nih.gov/pubmed/21423210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.84 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|